Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 4, 2026 · Filed Nov 5, 2026
A Vanda Pharmaceuticals director paid $13K out of pocket for Vanda Pharmaceuticals shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$13,171
Shares × reported transaction price
<$25K
+3.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
7 days after results of Oct 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $3.88 on Nov 4, 2026, within 4% of its 52-week low, after a 23% drop over the previous 30 trading days
52-week range $3.75 (Nov 3, 2026) to $9.56 (Mar 10, 2026), 2% of the way up, from 250 adjusted closes. 30 trading days earlier: $5.04 on Sep 23, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.5% | +2.6% | +1.9% |
Past results only. Not a forecast.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Insider buying
Traded Nov 5 · filed the same day
A Vanda Pharmaceuticals director paid $22K out of pocket for Vanda Pharmaceuticals shares. Shares held went up 6% with this purchase.
Insider buying
First insider buy since Aug 2025Traded Nov 3 · filed 2 days later
A Vanda Pharmaceuticals director paid $2.8K out of pocket for Vanda Pharmaceuticals shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.